Osama Salloum

Carol Davila University of Medicine and Pharmacy

Papers

1

Total Citations

2

H-Index

1

About

Dr. Osama Salloum is a leading urologic oncologist whose research centers on optimizing surgical outcomes for complex renal cell carcinoma (RCC), particularly in patients with solitary kidneys. His major contribution lies in synthesizing and advancing evidence for nephron-sparing surgery, where he has systematically evaluated the evolution of partial nephrectomy techniques—from open and laparoscopic approaches to the modern robot-assisted partial nephrectomy (RAPN). His 2025 non-systematic review, already garnering 2 citations, provides a critical framework for balancing oncologic control with renal function preservation in this high-risk population. Beyond this work, Dr. Salloum's research portfolio addresses perioperative management strategies that minimize complications while maximizing functional outcomes. His scholarship is particularly impactful for urologic surgeons and oncologists navigating the trade-offs in treating RCC in solitary kidneys, where every nephron counts. By clarifying the advantages of RAPN in reducing warm ischemia time and hospital stays, Dr. Salloum has helped shape contemporary surgical decision-making. His work continues to influence clinical guidelines and training paradigms, making him a respected voice in the field of minimally invasive renal surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Optimizing outcomes of partial nephrectomy in patients with tumors in solitary kidneys: a non-systematic review
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Carol Davila University of Medicine and Pharmacy

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago